Cost-effectiveness of anti-SARS-CoV-2 antibody diagnostic tests in Brazil.
Tália Santana Machado de AssisMariana Lourenço FreireJanaína de Pina de CarvalhoAna RabelloGláucia Fernandes CotaPublished in: PloS one (2022)
Nowadays there are few indications for the use of serologic tests in the diagnosis of COVID-19 and numerous commercially available tests, with marked differences are observed among them. In general, LFA tests are more cost-effective for estimated low-COVID-19-prevalences, while ELISAs are more cost-effective for high-pretest-probability scenarios.